Time Medical International Ventures Announces Development of Inter-Op MRI Under the Leadership of Dr. Iype Cherian
Time Medical International Ventures (I) P LTD, a wholly owned subsidiary of Fischer Medical Ventures Limited, today announced a strategic collaboration with globally acclaimed neurosurgeon Dr. Iype Cherian, , a pioneering neurosurgeon, educator, and innovator of international repute to develop a revolutionary new variant of MRI technology — DRIS–iMRI Medharanya.
31st October 2025 – Chennai – Time Medical International Ventures (I) P LTD is a global leader in advanced medical imaging solutions and a wholly owned subsidiary of Fischer Medical Ventures Ltd. Headquartered in Chennai, Time Medical India specializes in the design and manufacture of high-performance, cost-effective MRI systems that democratize access to advanced diagnostic imaging across emerging and developed markets alike.
Through this collaboration, Time Medical and Dr. Cherian will jointly develop a revolutionary new variant of MRI technology — DRIS–iMRI Medharanya, an AI-enabled, next-generation, portable and specialized MRI system integrating augmented reality (AR), artificial intelligence (AI), machine learning (ML), and exoscope technologies.
The Interop MRI is designed to revolutionize interoperative imaging, providing surgeons with real-time visualization during complex neurosurgical procedures. This innovation enables unprecedented precision, safety, and control in surgeries that traditionally
rely on limited visual feedback.
DRIS–iMRI Medharanya represents a next-generation, AI-enabled, portable MRI system that integrates Augmented Reality (AR), Artificial Intelligence and Machine Learning (AI/ML), and Exoscope technologies. Designed to transform neurosurgical and neurodiagnostic practice, it enables unparalleled precision, visualization, and accessibility in real-time interoperative imaging.
Clinically, DRIS–iMRI Medharanya also embodies the Extradural Parasigmoid approach to the Jugular Foramen (Ex Pa JuF) — a groundbreaking surgical pathway for managing complex glomus tumours with enhanced safety and anatomical clarity.
About Dr. Iype Cherian
Dr. Iype Cherian is a pioneering neurosurgeon, educator, and innovator whose distinguished career embodies surgical mastery, inventive spirit, and global impact. After completing his M.Ch (Neurosurgery) at CMC Vellore and a Fellowship in Skull Base and Vascular Neurosurgery at Nagoya, he has devoted his life to advancing neurosurgical science and education. His groundbreaking contributions include the description of Craniotomy (2007) and the concept of Brain Cooling, both of which have influenced contemporary neurosurgical practice and postoperative recovery strategies.
Renowned for “Unlocking the Skull Base,” he has developed advanced microsurgical routes such as the Transcavernous and Modified Kawase approaches, creating safer access to complex intracranial regions. His inventive portfolio — including the Sanma Yoko Exoscope, STMC Bypass Set, Medharanya Theatre Concept, Sookshmaranga Endovascular Robot, and now DRIS–iMRI Medharanya — reflects his mission to democratize precision surgery.
Currently serving as Director of Neuro Sciences at the Parul Institute of Medical Sciences & Research and as faculty at the Institute of NeuroSciences, Krishna Institute of Medical Sciences, Karad, he continues to mentor surgeons worldwide through Neurosurgery Coach, his global training initiative promoting advanced micro-neurosurgical skill development.
Under this collaboration, Dr. Iype Cherian will assume the role of Director – Neurosciences at Time Medical India, where he will guide the clinical innovation, neuroimaging design, and translational strategy of the DRIS–iMRI Medharanya program. This partnership reflects Time Medical’s commitment to advancing imaging technology that bridges intelligence, accessibility, and human-centered design.
Quotes
Dr. Iype Cherian, Neurosurgeon at Parul University, explained:
“Glioma surgery is generally a blind surgery. Interoperative MRI gives vision to the surgeon — allowing them to see what has been taken and what is left. Small interparenchymal lesions would be much easier to remove definitively if live imaging were available interoperatively.”
Ms. Svetlana, Director, Time Medical International Ventures (I) P Ltd:
“With Dr. Cherian’s expertise and vision, Time Medical is entering an exciting new phase of innovation. The Interop MRI represents our commitment to developing cutting-edge, accessible solutions that bring world-class imaging into the surgical environment.”
